Bone Marrow Aspirate Concentrate
Phase 3Biologic
Bone Marrow Aspirate Concentrate is one of 67 biologic programs targeting Osteoarthritis. It is currently in Phase 3.
5
Indications
7
Total Trials
6
Active Trials
66
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
143 competitors in Osteoarthritis
#DrugCompanyPhaseTrials
1Bone Marrow Aspirate Concentrate
MMassachusetts General Hospital
Phase 3
Toradol
RochePreclinical
Cataflam
NovartisPreclinical
Bayer Aspirin
BayerPreclinical
Enbrel
IImmunex
Preclinical
Glucophage
EMD SeronoPreclinical
Precedex
MMcNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.
Preclinical
Protonix
WWyeth-Lederle Vaccines
Preclinical
Catapres
Boehringer IngelheimPreclinical
MS Contin
HHikma Pharmaceuticals LLC
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Osteoarthritis2 trials
Functional Outcomes1 trial
Sources
References
- [1]
- [2]
- [3]
- [4]
Details
Drug Info
Quick Facts
- Modality
- Biologic[2]
- Highest Phase
- Phase 3[1]
- Company
- MMassachusetts General Hospital